NO870779D0 - SOLUBILIZATION OF PROTEINS FOR PHARMACEUTICAL PREPARATIONS USING POLYMER CONJUGATION. - Google Patents
SOLUBILIZATION OF PROTEINS FOR PHARMACEUTICAL PREPARATIONS USING POLYMER CONJUGATION.Info
- Publication number
- NO870779D0 NO870779D0 NO870779A NO870779A NO870779D0 NO 870779 D0 NO870779 D0 NO 870779D0 NO 870779 A NO870779 A NO 870779A NO 870779 A NO870779 A NO 870779A NO 870779 D0 NO870779 D0 NO 870779D0
- Authority
- NO
- Norway
- Prior art keywords
- solubilization
- proteins
- pharmaceutical preparations
- polymer conjugation
- conjugation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
- C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2013—IL-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/215—IFN-beta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
- A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
- A61K47/6811—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
- A61K47/6817—Toxins
- A61K47/6819—Plant toxins
- A61K47/6825—Ribosomal inhibitory proteins, i.e. RIP-I or RIP-II, e.g. Pap, gelonin or dianthin
- A61K47/6827—Ricin A
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Molecular Biology (AREA)
- Botany (AREA)
- General Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US74995585A | 1985-06-26 | 1985-06-26 | |
PCT/US1986/001252 WO1987000056A1 (en) | 1985-06-26 | 1986-06-06 | Solubilization of proteins for pharmaceutical compositions using polymer conjugation |
Publications (4)
Publication Number | Publication Date |
---|---|
NO870779D0 true NO870779D0 (en) | 1987-02-25 |
NO870779L NO870779L (en) | 1987-02-25 |
NO171295B NO171295B (en) | 1992-11-16 |
NO171295C NO171295C (en) | 1993-02-24 |
Family
ID=26773725
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO870779A NO171295C (en) | 1985-06-26 | 1987-02-25 | PROCEDURE FOR PREPARING A PHARMACEUTICAL PREPARATION IN THE FORM OF A BIOLOGICALLY ACTIVE CONJUGATED PROTEIN |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU580431B2 (en) |
NO (1) | NO171295C (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1297003C (en) * | 1985-09-20 | 1992-03-10 | Jack H. Nunberg | Composition and method for treating animals |
CA1283046C (en) * | 1986-05-29 | 1991-04-16 | Nandini Katre | Tumor necrosis factor formulation |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4179337A (en) * | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
US4414147A (en) * | 1981-04-17 | 1983-11-08 | Massachusetts Institute Of Technology | Methods of decreasing the hydrophobicity of fibroblast and other interferons |
EP0154316B1 (en) * | 1984-03-06 | 1989-09-13 | Takeda Chemical Industries, Ltd. | Chemically modified lymphokine and production thereof |
-
1986
- 1986-06-06 AU AU59700/86A patent/AU580431B2/en not_active Ceased
-
1987
- 1987-02-25 NO NO870779A patent/NO171295C/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU5970086A (en) | 1987-01-30 |
AU580431B2 (en) | 1989-01-12 |
NO870779L (en) | 1987-02-25 |
NO171295C (en) | 1993-02-24 |
NO171295B (en) | 1992-11-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3586313D1 (en) | CONJUGATES OF PHARMACEUTICAL USEFUL PROTEINS. | |
ZA864766B (en) | Solubilization of proteins for pharmaceutical compositions using polymer conjugation | |
DK360988D0 (en) | PHARMACEUTICAL CYCLODEXTRIN CONTAINING PREPARATIONS | |
NO922005D0 (en) | PHARMACEUTICAL PREPARATIONS | |
NO854194L (en) | PROCEDURE FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS CONTAINING ANTRACYCLING GYCOSIDES. | |
NO873534L (en) | STABLE PHARMACEUTICAL GEL PREPARATION. | |
DK149988D0 (en) | STABLE PHARMACEUTICAL PREPARATIONS | |
DK163923C (en) | 2-PHENYL-3-AMINOMETHYL-IMIDAZOOE1,2-AAAPYRIDINE DERIVATIVES AND PHARMACEUTICAL PREPARATIONS CONTAINING SUCH COMPOUNDS | |
DK413987D0 (en) | PHARMACEUTICAL PREPARATIONS | |
DK259186D0 (en) | NATIONAL PHARMACEUTICAL PREPARATIONS | |
NO872551D0 (en) | PROCEDURE FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS | |
DK652787D0 (en) | PHARMACEUTICAL PREPARATIONS | |
DK288686D0 (en) | PHARMACEUTICAL PREPARATIONS | |
DE3682960D1 (en) | PHARMACEUTICAL PREPARATIONS. | |
DK111686D0 (en) | SUSTAINABLE PHARMACEUTICAL PREPARATIONS | |
NO874193D0 (en) | PHARMACEUTICAL PREPARATIONS. | |
DK52086A (en) | PHARMACEUTICAL PREPARATIONS CONTAINING ERGOTAL KALOIDS | |
DK447887D0 (en) | PHARMACEUTICAL PREPARATIONS | |
NO870779D0 (en) | SOLUBILIZATION OF PROTEINS FOR PHARMACEUTICAL PREPARATIONS USING POLYMER CONJUGATION. | |
NO873423D0 (en) | PROCEDURE FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS | |
NO872233D0 (en) | PROCEDURE FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS | |
DE3671630D1 (en) | GLYCERO-3 (2) -PHOSPHO-L-SERINE DERIVATIVES AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM. | |
DK645988A (en) | BIPHENYL DERIVATIVES, PROCEDURES FOR PREPARING THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING SAME | |
DK149588A (en) | XYLOMETAZOLE-CONTAINING PHARMACEUTICAL PREPARATIONS | |
SE8504793D0 (en) | PHARMACEUTICAL PREPARATIONS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK1K | Patent expired |